Thoracic Oncology Program
Program Orientation/Overview
The Thoracic Oncology Program comprises a group of physician specialists who have the expertise to diagnose and treat lung cancer. Moffitt Cancer Center's Thoracic Oncology Program provides patients and referring physicians with the most current methods of care and support available in the world today. The Thoracic Oncology Program utilizes an interdisciplinary approach to evaluate and treat lung and other thoracic cancers. This approach includes a team of physicians specializing in medical oncology, pulmonology, surgery, pathology, radiation therapy and radiology. These specialists work together to ensure coordinated care, good communication and an aggressive approach to treatment. Patients also receive support from a team of skilled nurses, psychosocial workers and dieticians, and other healthcare professionals, all of whom have advanced education in caring for patients with lung cancer.
Our Cancer Center has the very best treatment options available; however, the best is still not good enough. That is why we are actively working on research and special treatments called clinical trials for many of our patients. We believe this is the most effective way for many patients to receive the best care possible, and for all of us to contribute to the prevention and cure of lung cancer in the future.
About Lung Cancer
Caring for patients with lung and other cancers in the chest requires close and effective coordination of multiple specialists and treatments during the different stages of the disease. The treatment team combines the skills of these specialties to ensure coordinated care, good communication and an aggressive approach to treatment.
A range of problems are addressed, including:
– Suspected lung cancer
– Newly diagnosed lung cancer
– Recurrent lung cancer
– Mesothelioma
– Thymoma
– Malignant effusions
– Lung metastases (a secondary cancer that has spread to the lung from another site)
– Follow-up of patient already treated
– Early detection and chemoprevention of lung cancer in high-risk individuals